Navigation Links
Resverlogix Notice of Conference Call & Webcast
Date:5/1/2008

TSX Exchange Symbol: RVX

CALGARY, May 1 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that it will host a live teleconference on May 8, 2008 at 9:00 pm MDT to provide a year-end update on both the science and the business aspects of the Company. Following the presentation there will be a live question and answer session.

The webcast can be accessed at the following link: http://services.choruscall.com/links/resverlogix0800508.html or on Resverlogix's website at: http://www.resverlogix.com.
Participants can also dial in for the conference call:

Dial information is as follows:

International Dial In: 1 604 638 5340

North America Toll Free: 1 800 319 4610

The webcast will be available on the Resverlogix website for replay for a period of 10 days after the event.

About Resverlogix Corp.

Resverlogix Corp. is a leading biotechnology company engaged in the development of novel therapies for important global medical markets with significant unmet needs. The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer's and other vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a program that aims to address burgeoning grievous diseases, such as cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit http://www.resverlogix.com.

This news release may contain certain forward-looking statements that reflect the current views
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM
2. Resverlogix is Presenting at IAS HDL Workshop
3. Resverlogix Honoured with World Economic Forum Technology Pioneer Award
4. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
5. Resverlogix Share Option Extension
6. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
7. Warner Chilcott Announces Receipt of Paragraph IV Certification Notice
8. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
9. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
10. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
11. YM BIOSCIENCES NOTICE OF ANNUAL MEETING OF SHAREHOLDERS AND NOMINATION OF DIRECTORS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Senior supply chain management executives from over ... challenges of “Reducing Cost, Lead Time, & Defects in ... Describing the partnership of the Bio Supply Management Alliance ... ( SCMI) of the University of San Diego ... Kroc Institute of Peace and Justice in San Diego, ...
(Date:7/10/2014)... , July 10, 2014  Kainos Capital, a firm ... today announced that it has acquired the Slim-Fast brand ... the business. Terms of the transaction were not disclosed. ... meal replacement business that markets ready-to-drink shakes, powders, bars ... America and in the United ...
(Date:7/10/2014)... July 10, 2014   Ceres, Inc . (Nasdaq: ... company, announced today financial results for the three months ... its business. Ceres reported that the company ... performance this growing season in Brazil, which concluded in ... company,s sorghum evaluation areas for part of the growing ...
(Date:7/10/2014)... microscopic polymer light resonators that expand in the ... Photonics Laboratory have developed new optical sensors with ... sensors are ideal for detecting trace gas concentrations ... nature, and immunity to electromagnetic interference. , Although ... the MIT team conceived an extremely sensitive, compact ...
Breaking Biology Technology:Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Kainos Capital Acquires Slim-Fast From Unilever 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Swell new sensors 2
... ILI ), announced today that it will host ... at 4:30 p.m. ET to review the Company,s,first quarter ... developments., To access the live call, dial 877-627-6555 ... on the Investors,section of the Company,s website, http://www.ilgenetics.com ...
... Pharmaceuticals, Inc.,(Nasdaq: AMLN ) will be presenting at ... 2008 at 10:00 a.m. PT in Las Vegas. Michael,York, ... providing a corporate overview., The live presentation and ... made available following the event. The webcast and,recording will ...
... to augment Quintiles Consulting offerings, RESEARCH ... Corp. today announced that it has signed ... decision-analytics and market research,consulting firm located in ... business., The acquisition of Eidetics will ...
Cached Biology Technology:Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results 2Quintiles Signs Agreement to Acquire Eidetics 2
(Date:7/10/2014)... overfishing in the English Channel has resulted in the ... left fishermen ,scraping the barrel, for increasing amounts of ... haddock and many other species at the head of ... removed from the area completely., These are some of ... at Plymouth University, in association with international non-profit research ...
(Date:7/10/2014)... at NJIT,s business incubator, received a $1.4 million federal ... use to staunch bleeding during brain surgery. , Surgeons ... the natural bio-polymer solutions in the gel will cohere ... , The gel can shorten an intracranial surgery ... time for the patient,s skull to be open and ...
(Date:7/10/2014)... that Courtney Aldrich, Ph.D., will head the brand-new, ... editor-in-chief. With the first issue slated for publication ... a growing demand for a place to publish ... is to develop a journal focused on diseases ... that advances the field and lays the foundation ...
Breaking Biology News(10 mins):Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 2Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 3A start-up at NJIT develops bleeding-control gel for brain surgery 2ACS Infectious Diseases: Unique chemistry journal names editor 2
... from a puddle or a pond to a vast ocean, ... animals. These so-called sessile suspension feeders are critical to aquatic ... contaminants by consuming bacteria. A study published by Cell Press ... that by actively changing the angle of their bodies relative ...
... time, it was thought impossible to isolate a pearl,s ... this elusive goal. Scientists Joana Meyer, from the ETH ... McDonald, and Laurent Cartier of the Swiss Gemmological Institute ... the first time in extracting trace amounts of DNA ...
... Oct. 7, 2013 ValidSoft, a global supplier of ... and a wholly owned subsidiary of Elephant Talk Communications ... commerce technology with Spindle,s new "MeNetwork360" mobile commerce ecosystem, ... ) conference being held from October 6 to October ...
Cached Biology News:How tiny organisms make a big impact on clean water 2A bad break for fake pearls 2ValidSoft and Spindle to Demo New Mobile Commerce Ecosystem at Money2020 2ValidSoft and Spindle to Demo New Mobile Commerce Ecosystem at Money2020 3ValidSoft and Spindle to Demo New Mobile Commerce Ecosystem at Money2020 4ValidSoft and Spindle to Demo New Mobile Commerce Ecosystem at Money2020 5
Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Rb anti-Occludin (C-term GST)...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
...
Biology Products: